SENATE FLOOR VERSION - SB1806 SFLR Page 1
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION
February 29, 2024
SENATE BILL NO. 1806 By: Rosino of the Senate
and
Boatman of the House
An Act relating to substance abuse services; defining
term; providing certain power and duty to the
Department of Mental Health and Substance Abuse
Services; requiring certain state agencies to execute
certain interagency agreements ; requiring certain
submission of data by state agencies and political
subdivisions; requiring the Department to compile and
submit certain annual report; p roviding for
codification; and providing an effective date .
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 2 -402 of Title 43A, un less there
is created a duplication in numbering, reads as follows:
A. As used in this section, “emergency opioid antagonist ” means
a drug including but not limited to naloxone that blocks the effects
of opioids and that is approved by the United States F ood and Drug
Administration for the treatment of an opioid overdose.
SENATE FLOOR VERSION - SB1806 SFLR Page 2
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. The Department of Mental Health and Substance Abuse Services
shall have the power and duty to coordinate and oversee the
distribution of emergency opioid antagonists by state agencies.
C. Any state agency that distributes emergency opioid
antagonists, including but not limited to the State Department of
Health, shall execute an interagency agreement with the Department
of Mental Health and Substance Abuse Services to coordinate the
distribution of emergency opioid antagonists .
D. Any state agency that distributes emergency opioid
antagonists, or any political subdivision that receives an opioid
grant award under the Political Subdivisions Opioid Abatement Grants
Act to purchase emerge ncy opioid antagonists for distribution, shall
submit data to the Department of Mental Health and Substance Abuse
Services on the agency’s or political subdivision ’s distribution of
emergency opioid antagonists including geographic data , data on the
entities receiving emergency opioid antagonists from the agency , and
any other data requested by the Department of Mental Health and
Substance Abuse Services .
E. The Department of Mental Health and Substance Abuse Services
shall compile an annual report summari zing and analyzing the data
submitted by state agencies and political subdivisions under
subsection D of this section and its own data on distribution of
emergency opioid antagonists during the prior state fiscal year and
shall, beginning December 1, 2025, electronically submit the report
SENATE FLOOR VERSION - SB1806 SFLR Page 3
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
to the President Pro Temp ore of the Senate, the Speaker of the House
of Representatives, and the Governor no later than December 1 of
each year.
SECTION 2. This act shall become effective November 1, 2024.
COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES
February 29, 2024 - DO PASS